The Creating Hope Act of 2011 would encourage the creation of new drugs for underserved children who suffer from serious and rare medical conditions, including life-threatening cancers, by providing a voucher to pharmaceutical companies who develop such drugs. This voucher could be used to

The Creating Hope Act of 2011 provides market incentives to pharmaceutical companies to develop drugs for pediatric rare diseases.

PEDIATRIC CANCER Two weeks after Kids v Cancer Founder Nancy Goodman’s eight year old son, Jacob, was diagnosed with medulloblastoma, a rare form of pediatric brain cancer, doctors gave him a round of chemotherapy. Jacob’s tumors did not respond. Why then, didn’t Jacob’s medical team change his chemotherapy protocol? Because in the last 30 years, no new drugs have been developed to treat Jacob’s form of cancer. In fact, in the past 20 years, only one drug has been expressly developed for any form of pediatric cancer. Jacob died on January 16, 2009 when he was ten years old. http://wp.me/1cg8a